Regarding PCa, an in vitro study demonstrates that GALNT14 was upregulated in the castration-resistant prostate carcinoma cell line PC-3, which stably expressed the metastasis suppressor CD82 (37). The gene discussed is CD82; the disease is prostate carcinoma.